| Name | Trellus Health |
|---|---|
| Epic | TRLS |
| Isin | GB00BNNFM402 |
| Industry | Medical Equipment and Services |
| Latest share price | 2.40p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £3.88 | Debt ratio | n/a |
| Shares in issue | 161.51 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -55.02 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -0.04 | 52-week high / low | 0.53p / 5.10p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Trellus Health |
|---|---|
| Address | Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ |
| Telephone | +44 (0)20 7933 8787 |
| Website | http://www.trellushealth.com/investors |
| Director | Position |
|---|---|
| Dr Marla Dubinsky | CEO |
| Mr Traci Entel | Non-Executive Director |
| Mr Erik Kristian Lium | Non-Executive Director |
| Mr Brian E Griffin | Non-Executive Director |
| Mr David Michael Salter | Non-Executive Director |
| Mr Kevin L. Murphy Jr. | Non-Executive Chairman |
| Assets $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 7.92 | 6.49 | 4.28 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 7.96 | 6.55 | 4.36 |
| Inventory / work in progress | n/a | n/a | 0.45 |
| Trade and other receivables | 0.16 | 0.28 | 31.98 |
| Cash and equivalents | 12.17 | 19.09 | n/a |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 20.29 | 25.91 | 36.8 |
| Liabilities $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 0.79 | 0.82 | 1.52 |
| Long term liabilities | n/a | n/a | n/a |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 0.79 | 0.82 | 1.52 |
| Net assets $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 19.5 | 25.09 | 35.27 |
| Equity $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 0.14 | 0.14 | 0.14 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -21.81 | -15.47 | -6.66 |
| Share premium account | 43.39 | 43.39 | 43.39 |
| Total equity | 19.5 | 25.09 | 35.27 |
| Income $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -6.8 | -8.81 | -5.9 |
| Pre-tax profit | -6.34 | -8.81 | -5.9 |